Back to top
more

Chemours (CC)

(Real Time Quote from BATS)

$12.07 USD

12.07
1,607,319

+0.07 (0.58%)

Updated Aug 7, 2025 01:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (231 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Should Value Investors Consider Chemours (CC) Stock Now?

by Zacks Equity Research

Let's see if The Chemours Company (CC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.

    Tracey Ryniec headshot

    The Key to Spotting a Value Trap

    by Tracey Ryniec

    Just because a stock sinks and has a low P/E, doesn???t mean it's a value stock. Learn how to spot a true value stock from a value trap.

      Anindya Barman headshot

      Chemours (CC) Earnings, Revenues Trump Estimates in Q2

      by Anindya Barman

      Chemours (CC) topped expectations in Q2 on strong results across its business segments.

        Zacks Equity Research

        Chemours (CC) Q2 Earnings and Revenues Top Estimates

        by Zacks Equity Research

        Chemours (CC) delivered earnings and revenue surprises of 11.76% and 0.76%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

          Zacks Equity Research

          Cabot (CBT) to Report Q3 Earnings: What's in the Cards?

          by Zacks Equity Research

          Cabot (CBT) is likely to see year-over-year revenue growth in Q3.

            Anindya Barman headshot

            Mosaic (MOS) to Post Q2 Earnings: What's in the Cards?

            by Anindya Barman

            Strong expected segment performance is likely to support Mosaic's (MOS) Q2 results.

              Zacks Equity Research

              LyondellBasell's (LYB) Q2 Earnings: What's in the Cards?

              by Zacks Equity Research

              LyondellBasell (LYB) expects to benefit from continued high operating rates in Q2. However, scheduled maintenance may weigh on results.

                Anindya Barman headshot

                Chemical Stock Q2 Earnings Slated on Aug 2: DWDP, WLK & More

                by Anindya Barman

                Chemical companies are likely to gain from strategic actions and a favorable demand environment in Q2.

                  Zacks Equity Research

                  Westlake Chemical's (WLK) Q2 Earnings: Is a Beat Likely?

                  by Zacks Equity Research

                  Westlake Chemical (WLK) revenues are projected to increase on benefits from acquisition.

                    Anindya Barman headshot

                    DowDuPont (DWDP) Q2 Earnings: Is Another Beat in Store?

                    by Anindya Barman

                    DowDuPont (DWDP) is likely to gain from continued strong demand, higher pricing and cost synergies in Q2.

                      Zacks Equity Research

                      Univar (UNVR) to Report Q2 Earnings: What's in the Offing?

                      by Zacks Equity Research

                      Most segments of Univar (UNVR) are expected to witness a year-over-year improvement in Q2 revenues.

                        Zacks Equity Research

                        Will Higher Prices Drive CF Industries' (CF) Q2 Earnings?

                        by Zacks Equity Research

                        CF Industries' (CF) Q2 results are likely to benefit from higher prices across most segments.

                          Anindya Barman headshot

                          U.S. Steel (X) Warms Up to Q2 Earnings: What's in the Cards?

                          by Anindya Barman

                          U.S. Steel (X) is likely to gain from higher steel pricing in the second quarter.

                            Anindya Barman headshot

                            FMC Corp (FMC) Q2 Preview: Will the Earnings Streak Continue?

                            by Anindya Barman

                            Strong segment performance is expected to support FMC Corp.'s (FMC) earnings in Q2.

                              Zacks Equity Research

                              Will Sandbox Boost U.S. Silica's (SLCA) Earnings in Q2?

                              by Zacks Equity Research

                              U.S. Silica (SLCA) expects improved pricing and volumes for Sandbox.

                                Anindya Barman headshot

                                Arconic (ARNC) Q2 Earnings Preview: What's in the Cards?

                                by Anindya Barman

                                Arconic (ARNC) is expected to gain from its cost reduction and productivity improvement actions in Q2.

                                  Zacks Equity Research

                                  Platform Specialty (PAH) Up 22% in 3 Months: Here's Why

                                  by Zacks Equity Research

                                  Platform Specialty's (PAH) shares ride on forecast-topping earnings performance and upbeat outlook.

                                    Anindya Barman headshot

                                    Chemical Production on the Upswing: 5 Growth Stocks to Buy

                                    by Anindya Barman

                                    As the chemical industry's upturn is expected to continue, it will be a prudent idea to zero in on these stocks with compelling growth prospects.

                                      Zacks Equity Research

                                      Praxair Seals European Asset Sale Deal With Taiyo Nippon

                                      by Zacks Equity Research

                                      Praxair's (PX) agreement to divest majority of its European businesses to Taiyo Nippon Sanso drives a step toward Praxair-Linde merger.

                                        Zacks Equity Research

                                        Newmont (NEM) Achieves Commercial Production at Twin Creeks

                                        by Zacks Equity Research

                                        Newmont's (NEM) Twin Creeks Underground expansion project will add 30,000-40,000 ounces of gold per annum at all-in sustaining costs of $650-$750 per ounce.

                                          Zacks Equity Research

                                          U.S. Steel (X) Up 54% in a Year: What's Behind the Rally?

                                          by Zacks Equity Research

                                          Forecast-topping earnings performance, upbeat outlook and trade actions on imported steel have contributed to the run up in U.S. Steel's (X) shares.

                                            Anindya Barman headshot

                                            5 Reasons to Add Ashland (ASH) Stock to Your Portfolio

                                            by Anindya Barman

                                            Upbeat outlook and strong growth prospects make Ashland (ASH) an attractive investment option.

                                              Zacks Equity Research

                                              Ingevity (NGVT) Stock Up 43% in a Year: What's Driving it?

                                              by Zacks Equity Research

                                              Ingevity's (NGVT) shares ride on forecast-topping earnings performance, upbeat outlook and bright prospects from the Georgia-Pacific's pine chemicals business buyout.

                                                Zacks Equity Research

                                                Here's Why You Should Add U.S. Steel (X) to Your Portfolio

                                                by Zacks Equity Research

                                                Upbeat outlook and strong growth prospects make U.S. Steel (X) an attractive investment option.

                                                  Zacks Equity Research

                                                  Here's Why You Should Add FMC Corp (FMC) to Your Portfolio

                                                  by Zacks Equity Research

                                                  Upbeat outlook and strong growth prospects make FMC Corp (FMC) an attractive investment option.